{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:46:34Z","timestamp":1785509194697,"version":"3.56.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>In recent years, the incidence of cardiovascular disease (CVD) has risen steadily, significantly impacting public health. Subclinical hypothyroidism (SCH) remains a controversial risk factor for CVD. This review examines the associations between SCH and dyslipidemia, carotid intima-media thickness (C-IMT), cardiac dysfunction, and cardiovascular event risk. Evidence suggests SCH may exacerbate atherosclerosis and cardiac dysfunction through mechanisms such as increased LDL synthesis, oxidative stress, and impaired vascular endothelial function. However, the causal link between SCH and cardiovascular outcomes remains unclear due to study design heterogeneity and overreliance on TSH levels. Elevated TSH may not solely reflect thyroid dysfunction but could also indicate compensatory responses to inflammation, aging, or stress. Large-scale studies like NHANES and IPD meta-analyses show a strong association between SCH and cardiovascular risk in younger populations, which diminishes in older adults due to physiological TSH increases. The cardiovascular benefits of levothyroxine (L-T4) therapy in SCH patients are limited, especially in older individuals, where a narrow therapeutic window increases side effect risks. Studies relying solely on TSH as a diagnostic and therapeutic target have significant limitations, as TSH cannot distinguish adaptive thyroid adjustments from pathological states and overlooks the role of free thyroid hormones (FT3\/FT4). Future research should integrate multi-dimensional markers (such as oxidative stress indicators, vascular elasticity measures, and thyroid antibody status) and adopt longitudinal study designs to more accurately assess the clinical significance of SCH.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1527271","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T14:29:08Z","timestamp":1743776948000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Research status of subclinical hypothyroidism promoting the development and progression of cardiovascular diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Peijie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","first-page":"591588","DOI":"10.3389\/fendo.2020.591588","article-title":"Levothyroxine for the treatment of subclinical hypothyroidism and cardiovascular disease","volume":"11","author":"Sue","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1603825","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","volume":"376","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1408684","DOI":"10.3389\/fendo.2024.1408684","article-title":"Hypothyroidism and metabolic cardiovascular disease","volume":"15","author":"Patrizio","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","article-title":"The epidemiology of thyroid disease","volume":"99","author":"Vanderpump","year":"2011","journal-title":"Br Med Bull"},{"key":"B7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1210\/er.2012-1076","article-title":"Thyrotropin secretion patterns in health and disease","volume":"34","author":"Roelfsema","year":"2013","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"542710","DOI":"10.3389\/fendo.2020.542710","article-title":"The two faces of Janus: why thyrotropin as a cardiovascular risk factor may be an ambiguous target","volume":"11","author":"Dietrich","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"942971","DOI":"10.3389\/fcvm.2022.942971","article-title":"Minor perturbations of thyroid homeostasis and major cardiovascular endpoints-physiological mechanisms and clinical evidence","volume":"9","author":"M\u00fcller","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/hep.23800","article-title":"A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate\/protein kinase A\/cyclic adenosine monophosphate-responsive element binding protein pathway","volume":"52","author":"Tian","year":"2010","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejim.2016.12.015","article-title":"Subclinical hypothyroidism, lipid metabolism and cardiovascular disease","volume":"38","author":"Delitala","year":"2017","journal-title":"Eur J Intern Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1194\/jlr.M047654","article-title":"Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver","volume":"56","author":"Zhang","year":"2015","journal-title":"J Lipid Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.dsx.2018.08.021","article-title":"The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes","volume":"13","author":"Fazaeli","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.metabol.2017.07.006","article-title":"Thyroid stimulating hormone exhibits the impact on LDLR\/LDL-c via up-regulating hepatic PCSK9 expression","volume":"76","author":"Gong","year":"2017","journal-title":"Metab Clin Exp"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e58181","DOI":"10.7759\/cureus.58181","article-title":"Lipid profile perturbations associated with subclinical hypothyroidism: a descriptive study","volume":"16","author":"Harrar","year":"2024","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12797","DOI":"10.3390\/ijms222312797","article-title":"Hypothyroidism-Associated dyslipidemia: potential molecular mechanisms leading to NAFLD","volume":"22","author":"Mavromati","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.26355\/eurrev_202109_26662","article-title":"Association of serum proprotein convertase subtilisin\/kexin type 9 (PCSK9) level with thyroid function disorders","volume":"25","author":"Yildirim","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2020.08.021","article-title":"Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study","volume":"312","author":"Janovsky","year":"2020","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.numecd.2017.07.002","article-title":"Replacement therapy with levothyroxine modulates platelet activation in recent-onset post-thyroidectomy subclinical hypothyroidism","volume":"27","author":"Desideri","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12944-015-0092-4","article-title":"LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation","volume":"14","author":"Zha","year":"2015","journal-title":"Lipids Health Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2478\/rjim-2021-0028","article-title":"The role of thyroid hormones in carotid arterial wall remodeling in women","volume":"60","author":"Saric","year":"2022","journal-title":"Rom J Intern Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.numecd.2016.06.005","article-title":"Subclinical hypothyroidism is associated with higher carotid intima-media thickness in cross-sectional analysis of the Brazilian longitudinal study of adult health (ELSA-Brasil)","volume":"26","author":"de Miranda \u00c9J","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1038\/s41598-018-22897-3","article-title":"Non-invasive markers of cardiovascular risk in patients with subclinical hypothyroidism: a systematic review and meta-analysis of 27 case control studies","volume":"8","author":"Yao","year":"2018","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/jcdd11040098","article-title":"The relationship between subclinical hypothyroidism and carotid intima-media thickness as a potential marker of cardiovascular risk: a systematic review and a meta-analysis","volume":"11","author":"Isail\u0103","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/eurheartj\/ehx050","article-title":"Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update","volume":"39","author":"Floriani","year":"2018","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"39207","DOI":"10.18632\/oncotarget.9393","article-title":"TSH inhibits SERCA2a and the PKA\/PLN pathway in rat cardiomyocytes","volume":"7","author":"Dong","year":"2016","journal-title":"Oncotarget"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1038\/s41598-018-22970-x","article-title":"Diffuse myocardial injuries are present in subclinical hypothyroidism: a clinical study using myocardial T1-mapping quantification","volume":"8","author":"Yao","year":"2018","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"bvac016","DOI":"10.1210\/jendso\/bvac016","article-title":"Meta-analysis on the association between thyroid hormone disorders and arterial stiffness","volume":"6","author":"Bernardi","year":"2022","journal-title":"J Endocr Soc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4183\/aeb.2016.450","article-title":"Variation tendency of coagulation parameters in different hypothyroidism stages","volume":"12","author":"Gao","year":"2016","journal-title":"Acta Endocrinol (Bucharest)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jth.13970","article-title":"The influence of thyroid function on the coagulation system and its clinical consequences","volume":"16","author":"Elbers","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B31","doi-asserted-by":"publisher","first-page":"109881","DOI":"10.1016\/j.biopha.2020.109881","article-title":"Regulation of nitric oxide production in hypothyroidism","volume":"124","author":"Gluvic","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cca.2022.01.006","article-title":"Hyperlipidemia and hypothyroidism","volume":"527","author":"Su","year":"2022","journal-title":"Clin Chim Acta"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0131776","DOI":"10.1371\/journal.pone.0131776","article-title":"Endothelial functioning and hemodynamic parameters in rats with subclinical hypothyroid and the effects of thyroxine replacement","volume":"10","author":"Gao","year":"2015","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1089\/thy.2017.0414","article-title":"Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies","volume":"28","author":"Moon","year":"2018","journal-title":"Thyroid"},{"key":"B36","doi-asserted-by":"publisher","first-page":"E6106","DOI":"10.1073\/pnas.1711978115","article-title":"Lack of group-to-individual generalizability is a threat to human subjects research","volume":"115","author":"Fisher","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2017.10.004","article-title":"Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer\u2019s disease pathology in older adults","volume":"62","author":"Brenowitz","year":"2018","journal-title":"Neurobiol Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism: a review","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e2308652121","DOI":"10.1073\/pnas.2308652121","article-title":"Longevity, demographic characteristics, and socio-economic status are linked to triiodothyronine levels in the general population","volume":"121","author":"Lawton","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","article-title":"Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation","volume":"136","author":"Baumgartner","year":"2017","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e016053","DOI":"10.1136\/bmjopen-2017-016053","article-title":"Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis","volume":"7","author":"Zhao","year":"2017","journal-title":"BMJ Open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12020-019-02050-4","article-title":"Novel uses of thyroid hormones in cardiovascular conditions","volume":"66","author":"Razvi","year":"2019","journal-title":"Endocrine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1089\/thy.2019.0535","article-title":"Clinical parameters are more likely to be associated with thyroid hormone levels than with thyrotropin levels: a systematic review and meta-analysis","volume":"30","author":"Fitzgerald","year":"2020","journal-title":"Thyroid"},{"key":"B45","doi-asserted-by":"publisher","first-page":"101473","DOI":"10.1016\/j.xcrm.2024.101473","article-title":"Effects of levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: an open-label randomized trial","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2020.9389","article-title":"Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial","volume":"324","author":"Jabbar","year":"2020","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s40618-023-02229-7","article-title":"Risks of suboptimal and excessive thyroid hormone replacement across ages","volume":"47","author":"Feldt-Rasmussen","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1001\/jama.2019.17274","article-title":"Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism","volume":"322","author":"Mooijaart","year":"2019","journal-title":"JAMA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"674841","DOI":"10.3389\/fendo.2021.674841","article-title":"Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: pooled individual results of two randomised controlled trials","volume":"12","author":"Zijlstra","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.amjmed.2020.01.018","article-title":"The impact of levothyroxine on cardiac function in older adults with mild subclinical hypothyroidism: a randomized clinical trial","volume":"133","author":"Gencer","year":"2020","journal-title":"Am J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"l2006","DOI":"10.1136\/bmj.l2006","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"BMJ"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e13499","DOI":"10.1111\/ijcp.13499","article-title":"The current debate over treatment of subclinical hypothyroidism to prevent cardiovascular complications","volume":"74","author":"Chrysant","year":"2020","journal-title":"Int J Clin Pract"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1527271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T14:29:10Z","timestamp":1743776950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1527271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":52,"alternative-id":["10.3389\/fcvm.2025.1527271"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1527271","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1527271"}}